Sylvester Comprehensive Cancer Center

E-mail a Friend

Melvin C. Gitlin, M.D.

General Information

Melvin C. Gitlin, M.D.

Languages

  • English
  • French

Certifications

  • American Board of Anesthesiology

Specialties

  • Anesthesiology
  • Pain Medicine-Anesthesiology

Roles

  • Professor of Clinical Anesthesiology; Vice-Chair of Clinical Affairs

Research Interests

  • A Randomized, Double Blind, Placebo Controlled Evaluation of Mivacurium Chloride in Women Undergoing Gynecologic Procedures. Burroughs Wellcome; 1994-1995 (Co-Principal Investigator)
  • A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Single Dose Ondansetron 8mg and Single dose Ondansetron 16mg for the Treatment of Opioid-Induced Nausea and Emesis in Subjects Experiencing Acute Pain. Galaxo Wellcome (Principal Investigator)
  • A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of SNXlll Administered in Gradually Increasing Doses to Patients with Chronic Severe Pain. Neurex Corporation; l996 (Co-Principal Investigator)
  • A Multi-Center, Randomized, Double-Blind, Parallel Study Comparing the Efficacy and Safety of Tramadol Hydrochloride Controlled-Released Tablets versus Ultram (R) versus Placebo in Patients with Chronic Back Pain. Purdue Pharma; 1997 (Principal Investigator)
  • A Multi-Center, Randomized, Double-Blind, Parallel Study Comparing the Efficacy and Safety of Tramadol Hydrochloride Controlled-Released Tablets versus Ultram (R) versus Placebo in Patients with Chronic Pain due to Osteoarthritis of the Knee. Purdue Pharma; 1997 (Principal Investigator)
  • A Multi-Center, Open-Label Study Evaluating the Safety and Tolerability of Tramadol Hydrochloride Controlled-Released Tablets in Patients with Chronic Pain. Purdue Pharma; 1998 (Principal Investigator)
  • Assessment of Safety and Tolerability of Oral Sustained Release Tramadol vs. Oral Immediate Release Tramadol in Patients with Chronic Non-Malignant Pain. Randomized, double-blind, multicenter trial with two parallel groups. Asta Medica; 1999 (Prinicipal Investigator)
  • Open Label, Sequential Crossover Evaluation of the Analgesic Dose Equivalence, Efficacy and Safety of Controlled- Release Oxymorphone (Numorphan CR) Relative to Controlled-Release Oxycodone (Oxycontin) and Controlled-Release Morphine (MS Contin) in Patients with Cancer Pain. Endo Pharmaceuticals; 1999 (Principal Investigator)
  • A Multicenter, Open Label Extention Study to Evaluate the Long-Term Safety and Effectiveness of Numorphan CR in Patients with Chronic Pain. Endo Pharmaceuticals; 2000 (Principal Investigator)

Awards

Who's Who in Medicine and Healthcare
Director-at-large
Chairman
Who's Who In America
Best Doctors in America

Education

1991 Fellowship
St. Christopher's Hospital for Children
1984 Residency
Thomas Jefferson University Hospital
1974 Internship
Abington Memorial Hospital
1973 MD
University of Pennsylvania
1969 B.A.
New York University

Publications

  • Scher C, El-Baghdadi M, Jones,K, Gitlin, MC. The influence of body weight on postoperative acute pain management. Pain Medicine 2005;6(2):178-179
  • Gitlin MC, Lipman AG. Chronic Nonmalignant Pain. in Pain Management for Primary Care Clinicians editor Lipmann AG. American Society of Health-System Pharmacists. Bethesda, Maryland 2004;153-164
  • Gitlin MC. The Journal as a University – Pain Management. Cancer Investigation 2004;22(4):629
  • Gitlin MC: Those who cannot remember the past… Pain Medicine 2003;4(l):4-7
  • Gitlin MC. President’s Message. Pain Medicine. 2003;4(2):116-117
  • Scher CS, Gitlin MC. Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fiberoptic intubation. Canadian Journal of Anaesthesia, 2003;50(6):607-610
  • Gitlin MC. Pain Medicine: A contemporary perspective on environmental analysis and strategic planning. Pain Medicine 2003;4(3):213-214
  • Gitlin MC. Strategic planning, operations management, and fiscal analysis and control: Organizational imperatives. Pain Medicine 2003;4(4):308-310
  • Gitlin MC. Neuropathic pain and the elderly. Clinical Geriatrics 2002;10:30-33

E-mail a Friend